AKR1B10 and metabolic dysfunction-associated steatohepatitis: Furthermore, in patients with metabolic (dysfunction)-associated Steatohepatitis (MASH), high expression of hepatic AKR1B10 is linked to reduced hepatic retinoid levels, exacerbating the progression from MASH to Hepatocellular Carcinoma (HCC) (58).